Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
2,874
Total Claims
$1.1M
Drug Cost
288
Beneficiaries
$3,820
Cost/Patient
Risk Score Breakdown 8/100
Score components are additive. Read full methodology
Peer Comparison vs. 5,101 Rheumatology providers
+184%
Opioid rate vs peers
11.6% vs 4.1% avg
-37%
Cost per patient vs peers
$3,820 vs $6,039 avg
+93%
Brand preference vs peers
14.6% vs 7.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
11.6%
Opioid Rate
332
Opioid Claims
$9,314
Opioid Cost
5.7%
Long-Acting Rate
Brand vs Generic
Brand: 417 claims · $1.0M
Generic: 2,434 claims · $58K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Adalimumab | 28 | $218K |
| Tofacitinib Citrate | 35 | $191K |
| Etanercept | 13 | $144K |
| Upadacitinib | 15 | $95K |
| Golimumab | 13 | $84K |
| Apremilast | 13 | $65K |
| Abatacept/Maltose | 13 | $53K |
| Apixaban | 27 | $29K |
| Semaglutide | 11 | $10K |
| Naloxegol Oxalate | 11 | $5,547 |
| Mirabegron | 11 | $5,320 |
| Budesonide/Formoterol Fumarate | 13 | $5,013 |
| Olmesartan Medoxomil | 21 | $3,179 |
| Rosuvastatin Calcium | 29 | $2,683 |
| Cevimeline Hcl | 15 | $2,669 |
Prescribing Profile
Patient Profile
74
Avg Age
76%
Female
1.23
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About